COVID-19 Spike Protein Sequence ‘100% Match’ to Sequence Patented in 2016 by Moderna, Study Shows | By Dr. Joseph Mercola | childrenshealthdefense.org/defender

A study published last month in Frontiers in Virology claims to have discovered that a sequence of the COVID-19 virus’ spike protein is a 100% match to a modified mRNA sequence patented by Moderna in 2016, and last month, Moderna CEO Stéphane Bancel proposed the COVID pandemic may have been the result of a lab leak.

Story at-a-glance:

  • A study published Feb. 21, 2022, in Frontiers in Virology claims to have discovered that a sequence of the virus’ spike protein is a 100% match to a modified messenger RNA (mmRNA) sequence patented by Moderna in 2016.
  • The genetic sequence patented by Moderna is part of a human DNA repair gene called MSH3. This patented sequence is found in SARS-CoV-2’s furin cleavage site in the spike protein — the part that gives the virus such easy access into human cells.
  • According to Moderna’s patent application, the gene sequence was modified “for the production of oncology-related proteins and peptides,” ostensibly for use in cancer research.
  • According to the researchers, the chance that SARS-CoV-2 would have randomly acquired this furin cleavage site through natural evolution is 1 in 3 trillion.
  • In a Feb. 24, 2022, interview, Moderna CEO Stéphane Bancel proposed the COVID-19 pandemic may have been the result of a lab leak.

Continue reading and see video on Source: COVID-19 Spike Protein Sequence ‘100% Match’ to Sequence Patented in 2016 by Moderna, Study Shows